Amaero (3DA) H2 2025 earnings summary

Executive summary

• Achieved a pivotal year with transition to commercial operations, expanding manufacturing and securing major supply agreements.

• Commissioned second EIGA Premium atomizer, completed $28M facility upgrade, and received AS9100D accreditation.

• Signed exclusive five-year supply agreement with Velo3D and three-year titanium bar supply agreement with Perryman.

• Ended FY2025 with $19.2M cash, $50.7M in tangible assets, and fully funded for the next capital plan phase.

Financial highlights

• FY2025 revenue reached $3.8M, up from $0.9M in FY2024, with $2.4M from powder sales and $1.4M from PM-HIP manufacturing.

• Net loss after tax was $24.4M (FY2024: $18.8M), reflecting ongoing investment in scaling operations.

• Gross profit was negative at $(1.47)M due to high cost of sales during ramp-up.

• Cash and cash equivalents at year-end were $19.2M, with net cash used in operations of $17M.

• Raised $47M in equity and secured a $35M EXIM Bank loan at 5.43% fixed interest.

Outlook and guidance

• Entered FY2026 with 80% of 1H revenue contracted; Q1 FY2026 revenue expected at A$5.5M, a 550% YoY increase.

• On track for significant revenue growth in FY2026 and targeting positive EBITDA in FY2027.

• Exploring a potential direct U.S. listing within 12 months.